eli lilly glp-1 receptor agonist products Wegovy Pill vs. Foundayo: Which Oral Is Better for Weight Loss? Eli Lilly & Co. presents

Comparative effectiveness: Head-to-head trials vs tirzepatide to quantify the incremental benefit Track the trials: Visit ClinicalTrials.gov to see all ongoing retatrutide studies, eligibility criteria for enrollment, and recruiting sites

doi: 10.1038/s41467-022-31328-x, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 88

Tirzepatide, another glucose-lowering medication known by the brand name Mounjaro, was approved for diabetes treatment in 2022 and is under fast-track review for weight loss

0.81] was observed after 6 months

Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS) Lancet Diabetes Endocrinol